Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.

A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants

NCT04543383 ·Status: COMPLETED ·Phase: PHASE1

Deep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome

NCT04597138 ·Status: COMPLETED

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects

NCT02949206 ·Status: COMPLETED ·Phase: PHASE1

Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery

NCT00110513 ·Status: COMPLETED ·Phase: PHASE3

Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism

NCT01264458 ·Status: COMPLETED

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

NCT05819125 ·Status: TERMINATED

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

NCT02608970 ·Status: COMPLETED ·Phase: PHASE1

Risk Factors for Venous Thromboembolism in the Community

NCT00011180 ·Status: COMPLETED

Variability of Whole Blood Clotting Time Measurements in Ex Vivo Human Blood Samples Spiked With Anticoagulants

NCT03296982 ·Status: COMPLETED

Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery

NCT00253851 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome

NCT00395265 ·Status: COMPLETED

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

NCT02591732 ·Status: COMPLETED

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

NCT02448901 ·Status: UNKNOWN

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

NCT00319228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment

NCT03196206 ·Status: COMPLETED ·Phase: PHASE1

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

NCT02945280 ·Status: TERMINATED ·Phase: PHASE4

Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

NCT04650087 ·Status: COMPLETED ·Phase: PHASE3

Calf Deep Vein Thrombosis Treatment Trial

NCT03590743 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

NCT00851864 ·Status: COMPLETED ·Phase: PHASE4

Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.

NCT00056550 ·Status: COMPLETED ·Phase: PHASE3

REVIparin-BRIDging-in a General Practice Setting in GErmany

NCT02579122 ·Status: TERMINATED

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

NCT01006876 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects

NCT03453060 ·Status: COMPLETED ·Phase: PHASE1

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED